BTSA will be atending “Seoul Food & Hotel 2012”, the international exhibition for food, drink, hotel, restaurant, food service, bakery and supermarket industries in Seoul (South Korea), from May 8-11.

We are hosted by Nata Spirits, our distributors in South Korea.

This exhibition represents an important meeting point as South Korea has one of the world’s fastest growing economies and a dinamic market of 48 million people.

HALAL

This certificate ensures that products are suitable for the Muslim community.

HEALTH CERTIFICATE

The General Health Certificate for Food Companies and Food is attached to the Spanish Agency for Food Safety and Nutrition of the Ministry of Health, Social Affairs and Equality, and, it intendeds to protect public health and the interests of consumers, facilitating the official control of the companies. BTSA, Biotecnologías Aplicadas, has been and is registered in the registry from their application and beginnings of its activities.

IP NO-GMO

The concept of Preserved Identity (IP) is related to the absence of genetically modified organisms (OMG or GMO) understanding by this those organisms to which their genetic information or DNA has been modified. The concept is also related to traceability, which means that we know the origin and all the steps that soy has made ​​to arrive to our facilities.

Therefore, our IP Traceability System ensures that our product range TOCOBIOL® and our Natural Tocopherols are obtained from non genetically modified soy.

BRC-IFS

BTSA will be attending FIC 2012 in Shangai from March 28 to30th, the most authorized professional exhibition on food ingredients and additives in China.

Food Ingredients China, with over 1000 exhibitors from more than 20 countries has become an annual gathering of domestic and foreign counterparts in food additives, ingredients and food industry in China and is widely recognized and well supported by colleagues from food circles. 

BTSA will be attending FIE 2011 Paris from November 29th to December 1st.
The Global Business Platform for Food & Beverage ingredients

Fi Europe is the event in 2011 that will deliver you key R&D, NPD, marketing and purchasing professionals from global food manufacturers. With more than 23,000 food & beverage professionals from over 100 countries expected, Fi Europe is the world's largest gathering of ingredients buyers and decision makers.

In its 25th anniversary, the primary event of the industry is expected to be larger than ever.

OXABIOL® is an Active Ingredient for the cosmetic & personal care industry made up of mixed Natural Tocopherols from NON-GMO vegetable oil and Ascorbyl Palmitate.

Enriched with Omega-3 DHA from microalgae oil (BIOMEGA-TECH® ALGAE) and Omega-3 ALA from Flax seed oil (ECOFLAX®), OXABIOL® is specially appropriate for cosmetics & personal care products, providing moisturization to the skin and a whitening effect. Besides its antioxidant effect , a clinical trial has shown that OXABIOL® improves and maintain natural skin moisture and has a depigmentation effect that enhances overall skin appearance.

OXABIOL® was successfully presented at the C.Q. Massó Technical Seminar “La Formulation Cosmetique Conjuguee au naturel” on October 6th, 2011 in Aix-en-Provence. The seminar was attended by leading French cosmetic manufacturers, who represent 33% of worldwide sales.

Last week, from October 10th to 14th, took place in Las Vegas, Nevada, the last edition of Supply Side West, the the world’s largest event for healthy and innovative ingredients, and BTSA was there in its own booth to seize all the business opportunities of this major event.

For CPG manufacturers, marketers and product developers, this must-attend event offers access to new suppliers, ingredients and ideas under one roof. BTSA joined thousands of food, cosmetic and supplement professionals at the one global event that brings them together, and made a very positive balance.

We also took the opportunity to establish new business contacts and to strengthen business relationships with our U.S. and Canada distributors, and where able to share with them all our news and new developments that we have been working on during the past months.

At the end, and after a lot of hard work, we are confident that this effort will be worthwhile, and we are sure that we'll notice the value of all those meetings and contacts with other companies very soon.  We cannot do anything else but to be satisfied and we'll be looking forward to be there next year!

OXABIOL® is an Active Ingredient for the cosmetic industry made up of mixed Natural Tocopherols from NON-GMO vegetable oil and Ascorbyl Palmitate. Enriched with Omega-3 DHA from microalgae oil and Omega-3 ALA from Flax seed oil. 

After our "Business Tour", we can only make a highly positive balance. We have taken one more step to growth and recognition by customers of the southern continent as a leading company in the biotechnology industry.

Conducting training courses on sales techniques and presentations as well as the full support of our factory and the commitment of our company to ensure the supply of our products, we have reinforced the good relations existing with our customers. A relationship that allowed us to have a significant presence in the southern market and that we have increased with a new customer base, thus laying the foundation for growth that promises excellent future prospects.

Another factor to note is our presence in FoodPro 2011, the sector's most important trade fair held in Sydney last July and that in its previous edition reached about 300 exhibitors.

BTSA Biotecnologías Aplicadas, under the PRONAOS Project which aims to research aimed at developing a new generation of food for weight control and prevention of obesity, has done research in a new derivative of oleic acid .

The research activities have focused on the characterization and functional analysis of two ingredients: hydroxyoleic acid 2 and omega-3 concentrates.  

This research has successfully managed to stabilize these ingredients and protect them against oxidation in isolation and long term periods, through its combination with naturalantioxidants produced by BTSA.

Foods fortified with functional ingredients have achieved great results in blind tastings, as they have not shown alterations in taste and smell of them. This allows us to modify the composition of the product without altering the organoleptic characteristics it possesses.

The PRONAOS project ("scientific research aimed at developing a new generation of food for weight control and prevention of obesity") is one of 14 major strategic industrial research projects approved in the fourth edition of the CENIT Programme, framed Ingenio in 2010.

The purpose of PRONAOS is investigating the factors that regulate systems controlling body weight for the development of food to weight management and obesity prevention, siding with the NAOS strategy.

Supported by the Ministry of Science and Innovation.
Funded by the CDTI

The results of the study conducted by CSIC (Superior Council for Scientific Research) through the Rancimat method, shows that TOCOBIOL® PLUS GP increases oxidative stability up to 153%.

The objective of the study is to compare the antioxidant activity of TOCOBIOL® versus oregano extract and tocopherols in vegetable oils (sunflower oil) at 120°C.

The main conclusions of the study were the following:

• TOCOBIOL® PLUS L-70 clearly shows a higher antioxidant activity when compared to oregano extract and tocopherols. Both products have been tested under the exact same conditions and at the same dose in order to obtain reproducible results.

• The addition of 1,000 ppm and 2.000 ppm of TOCOBIOL® PLUS L-70 increases the oxidative stability of sunflower oil in 103% and 115,6%, respectively, while the same doses of oregano extract and tocopherols only reaches an increase of 18,7% and 20,3%.

• When using a dose of 1,000 ppm TOCOBIOL® PLUS GP stability of sunflower oil increases approximately 64%. It is remarkable that a dose of 2,000 ppm TOCOBIOL® PLUS GP, we can reach an antioxidant activity of 16.2 Rancimat hours, resulting in an increase of stability of the oil of 153%. This shows that using products of our TOCOBIOL® range it can be reached a stability value twice as high as the original value. However this does not occur when using oregano extract and tocopherols, that only reaches an increase of oxidative stability of 20,3%.
   

* Study based on results of tests conducted by CSIC. The original data are archived and available for consultation. 

After the nomination of the new board, BTSA Biotecnologías Aplicadas will hold the presidency of BioMadrid.

Last June 14th, BioMadrid's General Assembly agreed to appoint the new Board which will be chaired by Mr. Ángel Fernández de la Puebla, on behalf of BTSA Biotecnologías Aplicadas.

BTSA will be joined on the leadership team of the association for the next two years by various renowned companies as Merck Serono, Agrenvec, Diomune or Genetrix.

"Illusion and work" was the proposal of the new president before his appointment. "We will work to raise the awareness of the association and to let people know what biotech firms are doing in Madrid. The general public needs to know that we work on matters as important as new treatments for cancer, better food or more efficient biofuels, and the difficulties that we found in these developments. "

These statements were quickly enshrined as the new elected Board informed the assembly of its disposal to defend the interests of the industry in the current economic crisis by strengthening the services offered to partners.

EFA’s  are unsaturated long-chain fatty acids that are essential to the health of the human body, which cannot produce them naturally on its own. Omega-3s, 6s and 9s are EFA’s but are not considered essential because they can be produced by our body. Technically our system only needs LNA (omega-3 linolenic acid) and LA (omega-6 linoleic acid) and it can use enzymes to convert these two into several different beneficial fatty acids such as the omega-3s eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as well as the omega-6 gamma-linoleic acid (GLA) and arachidonic acid (AA). However, the conversion from LNA to EPA and DHA is widely reported as inadequate. Research has shown the average conversion rate is between 2% and 15%, with the conversion to EPA much better than to DHA, which is further down the metabolic line. Considering this poor conversion, EPA- and/or DHA-containing ingredients have become popular in the EFA market segment.

In fact, the EFA market is being driven primarily from omega-3 fatty acids, which have been growing at 10 percent to 18 percent across different regions in the globe, according to Frost & Sullivan. The firm further reported 90 percent of the estimated $1.5 billion in global omega-3 revenues in 2010 (85 percent in North America and 93 percent in Europe) were from marine-source omega-3 ingredients, rich sources of EPA and DHA. Frost put the average global growth rate for base year 2010 at about 18 percent for both all-source and marine omega-3 ingredients.

This market is driven by a consistent stream of positive research on the health benefits of increased intake and consumption of omega-3 supplements and foods. “With regard to marine derived omega-3 fatty acids, the market has basically been driven by solid science,” said Baldur Hjaltason, sales and business development director for EPAX AS. “In 2001, there were 7,894 papers listed in PubMed on omega-3s; in 2008, they were up to 13,5000 papers. Thereof, 1127 were randomized control trials (RCT) and 288 based on meta-analysis and systematic reviews.” He added the success of the first marine omega-3 concentrate as a prescription drug in the United States has also got the attention of the consumer.

Natural Marketing Institute (NMI) has shown most consumers (87 percent) say scientific and clinical evidence of efficacy is why they buy and use any given supplement. The firm also noted out of a survey population comprised mostly of primary grocery shoppers, 23 percent used omega-3 supplements in 2009, up from 14 percent in 2004. Additionally, 19 percent feel deficient in omega-3s, and 23 percent feel deficient in fish oil, the most common source of omega-3 EPA and DHA.